
SINT Valuation
SINTX Technologies Inc
- Overview
- Forecast
- Valuation
- Earnings
SINT Relative Valuation
SINT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SINT is overvalued; if below, it's undervalued.
Historical Valuation
SINTX Technologies Inc (SINT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 4.09 is considered Undervalued compared with the five-year average of -17.12. The fair price of SINTX Technologies Inc (SINT) is between 75.84 to 77.12 according to relative valuation methord. Compared to the current price of 2.57 USD , SINTX Technologies Inc is Undervalued By 96.61%.
Relative Value
Fair Zone
75.84-77.12
Current Price:2.57
96.61%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.13
P/B
Median3y
0.37
Median5y
0.22
-112.03
FCF Yield
Median3y
-394.46
Median5y
-254.83
Competitors Valuation Multiple
The average P/S ratio for SINT's competitors is 521.27, providing a benchmark for relative valuation. SINTX Technologies Inc Corp (SINT) exhibits a P/S ratio of 4.09, which is -99.22% above the industry average. Given its robust revenue growth of -46.29%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap

SINT.O
SINTX Technologies Inc
4.09
Average P/S: 521.27
-46.29%
6.57M

CELZ.O
Creative Medical Technology Holdings Inc
3107.86
7.08M

CDIO.O
Cardio Diagnostics Holdings Inc
14.24
-94.10%
7.77M

STRR.O
Star Equity Holdings Inc
0.09
41.74%
6.77M

RSLS.O
ReShape Lifesciences Inc
0.63
-42.75%
7.21M

POAI.O
Predictive Oncology Inc
0.70
2170.69%
7.46M
People Also Watch

PALI
Palisade Bio Inc
0.860
USD
-9.19%

BTTR
Better Choice Company Inc
0
USD
+8.02%

OLB
OLB Group Inc
1.630
USD
+1.24%

LKCO
Luokung Technology Corp
0
USD
-88.89%

PW
Power REIT
1.180
USD
0.00%

OCTO
Eightco Holdings Inc
1.270
USD
-7.97%

ZCAR
Zoomcar Holdings Inc
0
USD
-20.20%

IFBD
Infobird Co Ltd
1.095
USD
+0.37%

TOVX
Theriva Biologics Inc
0.494
USD
+2.49%

OBLG
Oblong Inc
5.225
USD
+4.92%
FAQ

Is SINTX Technologies Inc (SINT) currently overvalued or undervalued?
SINTX Technologies Inc (SINT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 4.09 is considered Undervalued compared with the five-year average of -17.12. The fair price of SINTX Technologies Inc (SINT) is between 75.84 to 77.12 according to relative valuation methord. Compared to the current price of 2.57 USD , SINTX Technologies Inc is Undervalued By 96.61% .

What is SINTX Technologies Inc (SINT) fair value?

How does SINT's valuation metrics compare to the industry average?

What is the current P/B ratio for SINTX Technologies Inc (SINT) as of Jul 23 2025?

What is the current FCF Yield for SINTX Technologies Inc (SINT) as of Jul 23 2025?

What is the current Forward P/E ratio for SINTX Technologies Inc (SINT) as of Jul 23 2025?
